1. Kumar S. Vernal keratoconjunctivitis: a major review. Acta Ophthalmol. 2009; 87:133–47.
Article
2. Heydenreich A, Dietze U. Cryotherapy in vernal conjunctivitis. Klin Monbl Augenheilkd. 1981; 179:116–8.
3. Abiose A, Merz M. Cryosurgery in the management of vernal keratoconjunctivitis. Ann Ophthalmol. 1983; 15:744–7.
4. Tanaka M, Takano Y, Dogru M. . A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratocon- junctivitis. Cornea. 2004; 23:326–9.
5. Nishiwaki-Dantas MC, Dantas PE, Pezzutti S, Finzi S. Surgical re-section of giant papillae and autologous conjunctival graft in patients with severe vernal keratoconjunctivitis and giant papillae. Ophthal Plast Reconstr Surg. 2000; 16:438–42.
Article
6. Tse DT, Mandelbaum S, Epstein E. . Mucous membrane grafting for severe palpebral vernal conjunctivitis. Arch Ophthalmol. 1983; 101:1879–83.
Article
7. Bonnet M, Durand L. Results of treatment of intransigent vernal conjunctivitis by buccal mucosa graft. Bull Mem Soc Fr Ophtalmol. 1968; 81:215–29.
8. Guo P, Kheirkhah A, Zhou WW. . Surgical resection and amni-otic membrane transplantation for treatment of refractory giant papillae in vernal keratoconjunctivitis. Cornea. 2013; 32:816–20.
Article
9. Tseng SC, Espana EM, Kawakita T. . How does amniotic mem-brane work? Ocul Surf. 2004; 2:177–87.
Article
10. Meller D, Tseng SC. Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci. 1999; 40:878–86.
11. Meller D, Pires RT, Tseng SC. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br J Ophthalmol. 2002; 86:463–71.
Article
12. Hao Y, Ma DH, Hwang DG. . Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000; 19:348–52.
Article
13. Tseng SC, Li DQ, Ma X. Suppression of transforming growth fac-tor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999; 179:325–35.
14. Li DQ, Lee SB, Tseng SC. Differential expression and regulation of TGF-beta1, TGF-beta2, TGF-beta3, TGF-betaRI, TGF-betaRII and TGF-betaRIII in cultured human corneal, limbal, and con-junctival fibroblasts. Curr Eye Res. 1999; 19:154–61.
15. Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane trans-plantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997; 124:765–74.
Article
16. Tseng SC, Prabhasawat P, Barton K. . Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998; 116:431–41.
Article
17. Kheirkhah A, Casas V, Esquenazi S. . New surgical approach for superior conjunctivochalasis. Cornea. 2007; 26:685–91.
Article
18. Singh S, Pal V, Dhull CS. Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis. Indian J Ophthalmol. 2001; 49:241–5.
19. Choi W, Lim SG, Yoon KC. Effect of treatment with excision of papillae and supratarsal triamcinolone injection on refractory ver-nal keratoconjunctivitis. J Korean Ophthalmol Soc. 2010; 51:492–7.
Article